Guidance

National measles guidelines

How to manage cases of suspected measles: what patient details to take, who to notify and assessing risk of disease spreading in close contacts.

From:
UK Health Security Agency
Published
28 October 2010
Last updated
1628 February 2024 — See all updates

Applies to England

Documents

National measles guidelines

Ref: UKHSA publication gateway number GOV-16092GOV-16276

PDF, 9181.35 KBMB, 59 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Measles warn and inform letter

Ref: UKHSA publication gateway number GOV-16113

ODT, 30.132.5 KB

This file is in an OpenDocument format

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Measles factsheet

HTML

Details

This guidance for health professionals covers:

  • how to decide if a suspected case of measles is ‘likely’ or ‘unlikely’
  • case management – what lab tests should be done and the importance of oral fluid testing on all suspected cases
  • measles control – identifying vulnerable contacts and assessing their need for post-exposure prophylaxis
Published 28 October 2010
Last updated 1628 February 2024 + show all updates

  1. Clarification of responsibilities for risk assessment in healthcare settings page 37. Further product information added on immunoglobulin product, Cuvitru, page 35.

  2. Added factsheet and updated letter.

  3. Updated guidance see page 3 for change history.

  4. Updated guidance, including additional section on defining the time window for receiving post-exposure prophylaxis (PEP).

  5. Updated guidance.

  6. Added latest version of guidelines.

  7. Updated to reflect revised clinical advice.

  8. First published.